Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-104097
Filing Date
2025-08-06
Accepted
2025-08-06 16:19:41
Documents
16
Effectiveness Date
2025-08-06

Document Format Files

Seq Description Document Type Size
1 S-8 artv-20250806.htm S-8 90247
2 EX-5.1 artv-ex5_1.htm EX-5.1 17409
3 EX-23.1 artv-ex23_1.htm EX-23.1 2909
4 EX-FILING FEES artv_exfilingfees.htm   iXBRL EX-FILING FEES 77496
5 GRAPHIC img55638573_0.jpg GRAPHIC 5966
6 GRAPHIC img55638573_1.jpg GRAPHIC 5966
  Complete submission text file 0000950170-25-104097.txt   347597

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT artv_exfilingfees_htm.xml XML 14954
Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Filer) CIK: 0001817241 (see all company filings)

EIN.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289298 | Film No.: 251189920
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)